InterCure Ltd. (TASE:INCR) signed an agreement to acquire additional 7.43% stake in Regenera Pharma Ltd. from Bamot Investments (1996) Ltd. for ILS 3 million on September 11, 2016. As per the consideration, InterCure will issue its 5.5 million shares and 1 million warrants at a strike price of ILS 1 each for three years to Bamot. According to the deal conditions, the shares to be allotted to Bamot will be locked, and cannot be negotiated in the exchange for a period of 6 months. As of September 27, 2016 all the pre-conditions have been fulfilled. InterCure Ltd. (TASE:INCR) completed the acquisition of additional 7.43% stake in Regenera Pharma Ltd. from Bamot Investments (1996) Ltd. on September 27, 2016.